iCancer (ADVince) clinical trial begins

Share on FacebookShare on Google+Tweet about this on TwitterShare on LinkedIn
The clinical trial launches
The clinical trial launches

Thanks to your contributions the iCancer clinical trial has begun this month.

The Financial Times recently declared it the most successful crowdfunded medical trial ever. The campaign went global and viral and trended on Twitter – as we hoped and intended.

As we reported Vince Hamilton, having seen the publicity around the campaign, stepped forward and made up the funding gap.

The potential treatment, an oncolytic virus for neuroendocrine tumours which (potentially) targets and destroys the cancer cells and amplifies the anti-cancer cell immune response, is named Advince, in honour of Mr Hamilton.

The trial is a phase I/II trial focused on safety.

We simply cannot thank you enough.

Without you all this trial would not be taking place. And a potential life-saving treatment would still be sitting on the shelf in a freezer in Sweden.

Please stay tuned for further updates (including a film of the first patient) over the coming weeks.

Share on FacebookShare on Google+Tweet about this on TwitterShare on LinkedIn

Leave a Reply

Your email address will not be published. Required fields are marked *